Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Enrolling by invitation Observational

Is Gender a Factor in Patients With Subacromial Shoulder Pain?

NCT06758986 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2024-10-25
Last updated
2026-04-20

Condition(s) studied

Subacromial Pain Syndrome

Study summary

This study aimed to investigate the effects of gender on pain, functionality, range of motion, disability level and position sense parameters in patients with subacromial shoulder pain.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: 1. Being between the ages of 18-65 2. Being diagnosed with unilateral subacromial impingement syndrome 3. Not having received steroid injections or physical therapy for shoulder problems in the last 6 months 4. Having painful shoulder pain for the last 3 months 5. Being willing to participate in the study Exclusion Criteria: 1. Having a rheumatic, neurological, cardiovascular, psychiatric or systemic disorder 2. Having a surgical operation on the shoulder, cervical and thoracic region 3. Having a neurological deficit, fracture or history of fracture in the upper extremity 4. Having cervical radiculopathy 5. Having communication problems

Primary outcome measure(s)

  • Visual Analog Scale — 20 weeks

Trial sites (1)

FacilityCityRegionStatus
Kirsehir Ahi Evran University Kırşehir Merkez
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06758986 on ClinicalTrials.gov ↗ ← All trials in Turkey